skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Adult remover assunto: Patients remover Oncology remover Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Treatment patterns and outcomes in patients with non‐small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropaenia: Results from the MONITOR‐GCSF study
Treatment patterns and outcomes in patients with non‐small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropaenia: Results from the MONITOR‐GCSF study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment patterns and outcomes in patients with non‐small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropaenia: Results from the MONITOR‐GCSF study

Aapro, Matti ; Krendyukov, Andriy ; Höbel, Nadja ; Gascon, Pere

European journal of cancer care, 2019-07, Vol.28 (4), p.e13034-n/a [Periódico revisado por pares]

England: Hindawi Limited

Texto completo disponível

Citações Citado por
2
Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer
Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer

Abdel-Rahman, Omar

Future oncology (London, England), 2017-10, Vol.13 (25), p.2277-2284 [Periódico revisado por pares]

England: Future Medicine Ltd

Texto completo disponível

Citações Citado por
3
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

Abdel-Wahab, Reham ; Varadhachary, Gauri R ; Bhosale, Priya R ; Wang, Xuemei ; Fogelman, David R ; Shroff, Rachna T ; Overman, Michael J ; Wolff, Robert A ; Javle, Milind

Journal of hematology and oncology, 2018-05, Vol.11 (1), p.71-9, Article 71 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)

Abrisqueta, Pau ; Delgado, Julio ; Alcoceba, Miguel ; Oliveira, Ana Carla ; Loscertales, Javier ; Hernández‐Rivas, Jose A. ; Ferrà, Christelle ; Cordoba, Raul ; Yáñez, Lucrecia ; Medina, Angeles ; Motlló, Cristina ; Iacoboni, Gloria ; Villacampa, Guillermo ; González, Marcos ; Bosch, Francesc

British journal of haematology, 2020-09, Vol.190 (6), p.854-863 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
Clinical presentation and outcomes for adult ependymoma patients
Clinical presentation and outcomes for adult ependymoma patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical presentation and outcomes for adult ependymoma patients

Acquaye, Alvina A. ; Vera, Elizabeth ; Gilbert, Mark R. ; Armstrong, Terri S.

Cancer, 2017-02, Vol.123 (3), p.494-501 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
Transforming the nature of fatigue through exercise: qualitative findings from a multidimensional exercise programme in cancer patients undergoing chemotherapy
Transforming the nature of fatigue through exercise: qualitative findings from a multidimensional exercise programme in cancer patients undergoing chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Transforming the nature of fatigue through exercise: qualitative findings from a multidimensional exercise programme in cancer patients undergoing chemotherapy

ADAMSEN, L. ; MIDTGAARD, J. ; ANDERSEN, C. ; QUIST, M. ; MOELLER, T. ; ROERTH, M.

European journal of cancer care, 2004-09, Vol.13 (4), p.362-370 [Periódico revisado por pares]

Oxford, UK: Blackwell Science Ltd

Texto completo disponível

Citações Citado por
7
Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression
Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression

Agboyibor, Clement ; Dong, Jianshu ; Effah, Clement Y. ; Drokow, Emmanuel K. ; Pervaiz, Waqar ; Li, Dié ; Kang, Lei ; Ma, Xinli ; Li, Jian ; Liu, Zhenzhen ; Liu, Hong-Min

Cancer Control, 2021-10, Vol.28, p.10732748211051557-10732748211051557 [Periódico revisado por pares]

Los Angeles, CA: SAGE Publications

Texto completo disponível

Citações Citado por
8
Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma
Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma

Ahn, Hee Kyung ; Kim, Seok Jin ; Hwang, Deok Won ; Ko, Young Hyeh ; Tang, Tiffany ; Lim, Soon Thye ; Kim, Won Seog

Investigational new drugs, 2013-04, Vol.31 (2), p.469-472 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
9
Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
Material Type:
Artigo 		Adicionar ao Meu Espaço

Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant

Ailawadhi, Sikander ; Ogbonnaya, Augustina ; Murty, Sharanya ; Cherepanov, Dasha ; Schroader, Bridgette Kanz ; Romanus, Dorothy ; Farrelly, Eileen ; Chari, Ajai

Cancer medicine (Malden, MA), 2023-02, Vol.12 (3), p.3145-3159 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
10
Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer
Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer

Akdeniz, Nadiye ; Küçüköner, Mehmet ; Kaplan, Muhammet Ali ; Urakçı, Zuhat ; Karhan, Oğur ; Sezgin, Yasin ; Bilen, Erkan ; Ebinç, Senar ; Teke, Fatma ; Laçin, Şahin ; Alan, Özkan ; Ercelep, Özlem ; Işıkdoğan, Abdurrahman ; Yumuk, Perran Fulden

International journal of clinical oncology, 2020-12, Vol.25 (12), p.2015-2024 [Periódico revisado por pares]

Singapore: Springer Singapore

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (868)

Data de Publicação 

De até
Refinar
  1. Antes de1997  (6)
  2. 1997Até2002  (117)
  3. 2003Até2008  (100)
  4. 2009Até2015  (228)
  5. Após 2015  (420)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (115)
  2. Norueguês  (1)
  3. Mais opções open sub menu

Neste Assunto:

  1. Patients
  2. Aged
  3. Adult
  4. Humans
  5. Oncology

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.